Could This Be Pfizer's Next Blockbuster Vaccine?

Submitted by admin on September 10, 2021 - 11:00am

Source:

Motley Fool

News Tags:

Headline:

snippet:

Pfizer announced that it was starting its phase 3 clinical trial for its respiratory syncytial virus vaccine candidate, known as RSVpreF.
If phase 3 clinical results come close to replicating phase 2 results, as expected, Pfizer could have yet another blockbuster vaccine under its belt.
Although Pfizer is up 27% year to date, it still trades at an attractive valuation to accompany its great portfolio of products.

Search form